The relentless pursuit of effective cancer therapies drives significant innovation in pharmaceutical chemistry. At the heart of many advanced treatments lies the intricate synthesis of complex molecules, often requiring highly specific intermediate compounds. One such crucial intermediate is 4-(4-Amino-3-fluorophenoxy)-N-methylpicolinamide (CAS 757251-39-1), an indispensable component in the production of Regorafenib, a multi-kinase inhibitor used in treating certain types of cancer, including metastatic colorectal cancer and advanced gastrointestinal stromal tumors.

For pharmaceutical companies and contract research organizations (CROs) involved in the development and manufacturing of such vital drugs, securing a consistent supply of high-purity intermediates is non-negotiable. When you buy 4-(4-Amino-3-fluorophenoxy)-N-methylpicolinamide, you are essentially investing in the quality and efficacy of the final therapeutic product. As a reputable pharmaceutical intermediate supplier in China, we connect you with manufacturers dedicated to producing this compound with an assay of ≥98.0%, meeting stringent industry benchmarks.

The synthesis of Regorafenib is a multi-step process, and the quality of each intermediate directly impacts the overall yield and purity of the active pharmaceutical ingredient (API). Therefore, identifying a reliable CAS 757251-39-1 supplier who can provide detailed Certificates of Analysis (CoA) and robust documentation is critical. We understand that consistent product quality and timely delivery are paramount for our clients, especially when dealing with life-saving medications. This is why we partner with established manufacturing facilities.

When evaluating the Regorafenib intermediate price, it's important to consider the total cost of ownership, which includes not just the purchase price but also the assurance of quality, regulatory compliance, and supply chain security. We strive to offer competitive pricing on this essential pharmaceutical intermediate for sale, making advanced cancer therapy development more accessible. Our aim is to support your research and production needs efficiently.

We welcome all inquiries for 4-(4-Amino-3-fluorophenoxy)-N-methylpicolinamide, whether for R&D purposes or larger-scale manufacturing. Contact us to discuss your specific needs, request samples, and obtain a detailed quotation to ensure your supply chain remains robust and efficient.